GNPX
GNPX
NASDAQ · Biotechnology

Genprex Inc

$2.81
-0.48 (-14.59%)
As of Sep 28, 10:45 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +884.3% upside
Low Target $20.34
Average Target $27.66
High Target $35.38
Current Price $2.81
Current
$2.81
Target
$27.66
$20.34 $27.66 avg $35.38
Scenario Analysis
Bear Case
$20.34
623.8%
Low target
Base Case
$27.66
+884.3%
Avg target
Bull Case
$35.38
+1,159.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
Target vs 52W High
$27.66
-97.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%